Engaging Thought Leadership
Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
Immuno US 2024
28 - 29 October 2024 | San Diego, CA
Delivering advanced, commercially viable immunotherapies to meet unmet medical need
Immuno US 2024
Meet Our Expert Speakers
The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Advances in Immuno-Oncology US 2024: 28 - 29 October 2024, San Diego, USA
Carsten Schmitz
Executive Director in Early Clinical Development, Immunology,
Eli Lilly
Greg Deener
CEO,
iCell Gene Therapeutics
Hélène Kaplon
Translational and Clinical Project Leader in Immunology,
Servier
I-Ming Wang
Director,
Pfizer
Mihil Patel
Group Lead Cell and Gene Engineering,
LIfT Biosciences
William Jia
CSO & Co-Founder,
Virogin Biotech
More speakers for Advances in Immuno-Oncology US 2024 will be revealed here in the coming weeks
Linda Zhang
Scientist 4,
Genentech
Luc Nguyen
Head MSAT,
SANOFI
Philip Arlen
Chief Executive Officer,
Precision Biologics
Shantheri Pai
Associate Director - Clinical Operations, Oncology,
Gilead Sciences
Suzanne Coberly
Senior Director,
Bristol Meyers Squibb
Meet Our Esteemed Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Cellecta, Inc
Bronze Sponsor
Cellecta Inc. is a trusted provider of genomic products and services for drug target and biomarker discovery. Since 2006, we have collaborated with the world’s leading pharma, biotech, government, and academic institutions. We apply our extensive expertise in viral vector production, functional screening, custom cell engineering and multiplex qRT-PCR to help researchers find the genes that matter.
Network & Programme Sponsors
Sponsors of last year's event included
10X Genomics
Platinum Sponsor
10x Genomics was founded on the vision that this century will bring advances in biomedicine and transform the way we understand and treat disease. We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.
ABL, an Institut Mérieux Company
Exhibition and Tech Demo Sponsor
ABL is a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and manufacturing of virus for vaccine candidates, gene and cancer therapies. ABL's mission is to provide GMP viral vectors from early-stage to market, contributing to the success of their clients' innovations. ABL's CDMO services offer a one-stop-shop and end-to-end CMC including bulk drug substance, fill/finish of drug products, process and assay development, as well as regulatory support. ABL has a unique experience with a broad range of viral vectors including poxvirus, arenavirus, lentivirus and adeno associated virus (AAV). ABL is a subsidiary of the Institut Mérieux Group and operates from various locations in Europe and the US.
Batavia Biosciences B.V
Bronze Sponsor
About Batavia Biosciences Batavia Biosciences significantly contributes to ease human suffering from infectious diseases and cancer by leveraging our innovative technologies and in-depth know-how at all stages of the development trajectory, from the transition into early clinical studies, to navigating late stage clinical development and entering commercial manufacturing at higher speed, reduced costs, and with increased success. The company operates state-of-the-art development and manufacturing facilities in Europe and the US and, as part of the CJ CheilJedang global family, is building a strong position in global health with its strategic partners worldwide. For more information visit www.bataviabiosciences.com
Belgian Volition SRL
Network & Programme Sponsor
Volition is at the forefront of epigenetic immunoassay development, contributing to the drug discovery and development cycle from in-vitro target validation to human clinical trials. Esteemed collaborators and customers utilize our technology in oncology and immunotherapy applications. Our primary objective is to deliver actionable insights that streamline drug development processes, from early-stage discovery to clinical trials. Nu.Q® Discover assays have been validated in preclinical PD studies tracking epigenetic modification levels in response to epigenetic inhibitors with recent data presented at AACR demonstrating a dose-dependent reduction in specific Histone PTM levels by simple liquid biopsy. We have developed an assay for NETosis, quantifying the release of Neutrophil Extracellular Traps. This assay is being used to assess innate immune response in acute inflammatory conditions, including sepsis resulting from infectious disease and cancer. Our Ex-vivo – Synthetic Sepsis™ platform is designed to screen NETosis modulators and potential activators, providing ex-vivo human data ahead of First-in-Human (FIH) studies. Adhering to rigorous industry standards, our assays are available as RUO kits, with select assays, such as Nu.Q®- NETS, CE-marked for clinical use. For specialized requirements, we can develop new assays following CLSI development guidelines. Our R&D activities are anchored in Belgium, complemented by an innovation lab in California and offices in Texas, London, and Singapore. For more details and scientific data please visit, volition.com.
GemPharmatech LLC
Silver Sponsor
GemPharmatech Co., Ltd. specializes in generating genetically engineered mouse models (GEMMs) and providing trusted preclinical services to our customers. Our team of scientists has extensive experience creating animal models using cutting edge gene-editing technologies. Their expertise and commitment to animal model development has resulted in GemPharmatech having one of the world's largest collections of knockout and conditional knockout mice, known as our Knockout All Project (KOAP). We also have an impressive collection of humanized, immunodeficient, and disease models. Our goal is to provide our customers with the best resources to accelerate biomedical discovery and drug development.
.jpg?length=600&name=d8e23ffc-e6ae-4c31-8147-cd52fb4aa9b2-2-5668375logo-Nanion_logo_black_RGB_300dpi-(2).jpg){kind=logo}
Nanion Technologies
Network & Programme Sponsor
Nanion Technologies is a global leading life sciences tools company combining since more than 20 years exceptional instrumentation with trusted scientific support, to accelerate successful drug development and scientific discoveries. As a leading provider of automated patch clamp systems with a wide range of throughput capabilities and formats, we have expanded our product range to in vitro systems for membrane pump/transporter, bilayer recordings, contractility and cell analytics measurements. From studying the biophysical properties and pharmacological profile of ion channels and transporters in native and reconstituted membranes to understanding the effect of their modulation on cell survival and function, our state-of-the-art instrumentation has revolutionized drug discovery, lead optimisation and safety assessment. Here we launch the last product from Nanion Technologies, AtlaZ instrument for high-throughput impedance spectroscopy measurements, allowing simultaneous, label-free and time resolved monitoring of diverse cellular responses. With the capability to track live cells in a 6x 96-well plate configuration, AtlaZ operates across a range of frequencies (0.1 KHz – 100 KHz), unveiling nuanced information about cell confluence, providing insights into proliferation and cytotoxicity, as well as formation of tight junction in epithelial and endothelial cell lines. Easy to set-up and use, AtlaZ is provided with an easy-to-use user interface providing real-time and automated data analysis. Applications include: Cell Proliferation, Cytotoxicity, Immune Cell-Mediated Cytotoxicity, Cancer Immunotherapy, Immuno-Oncology, Receptor-mediated Signalling.
Sino Biological US Inc
Network & Programme Sponsor
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offers pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.
Standard BioTools
Silver Sponsor
Standard BioTools™, previously known as Fluidigm®, is driven by a bold vision – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research. From interrogating cell function and cancer-immune cell interactions to confidently determining new biomarkers or integrity of samples, Standard BioTools promotes the development of breakthrough medicines faster and better through the delivery of consistent, reliable and repeatable results.
Ultivue
Silver Sponsor
Ultivue provides researchers and scientists in translational medicine with multiplex biomarker assays and spatial image analysis for tissue phenotyping and digital pathology. Its proprietary InSituPlex® technology enables advanced exploration and interrogation of tissue samples for precision medicine research. These highly customizable solutions coupled with our scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs.
Scientists Develop First Mouse Model with Complete & Functional Human Immune System
The breakthrough in mouse models will allow researchers to study the human immune system in far greater detail at a far greater pace.
NHS Cancer Vaccine Launchpad to Give Thousands Access to Personalised Cancer Vaccines
NHS England aims to match up to 10,000 cancer patients to suitable personalised cancer vaccine clinical trials by 2030.
AI-Enabled Predictive Biomarker for Patient Response to Immunotherapy Using Easy-to-Measure Features
The predictive biomarker does not require multi-omic or screening data, but rather routine clinical features.
H5N1 Bird Flu Outbreaks: Effect on Vaccines
H5N1 outbreaks in the US have mobilised pandemic preparedness mechanisms with stockpiling of avian flu vaccines.
PeproTech: Cytokine Network Poster
PeproTech: Immunologic Networks Poster
DoubleTree by Hilton Hotel San Diego - Mission Valley
7450 Hazard Center Dr, San Diego, CA 92108
By Trolley
The closest Trolley stop to the hotel is Hazard Center Station – this stop is served by the Sycuan Green Line. The hotel is a 7 mins walk from the station. When alighting at this stop, walk north on Hazard Center East Driveway towards Hazard Center Drive. Then turn left and the hotel will be on your right.
By Car
There is self-parking available (garage parking) at the hotel for $34 (this may be subject to state local taxes). There is no valet parking at this venue. For further information please contact the hotel directly. For driving instructions and a map, please click here
By Air
San Diego International Airport – The DoubleTree by Hilton San Diego – Mission Valley is 7 miles from the International Airport. A single taxi ride to the hotel will cost approx. $40 and will take around 20 minutes. Transportation to/from the hotel is provided by Super Shuttle, Cloud 9, or other shuttle services for approx. $10-$15 per person. Please click here for more information on travelling to the hotel from the airport.
By Bus
The closest bus stop to the venue is Camino De La Reina & Mission Center Rd, which is a 13min walk away. When alighting at this stop, walk north on Mission Center Rd towards Camino De La Reina. Turn left onto Hazard Center Dr and then right on to Frazee Rd – the hotel should be on the right hand side. Please click here for more information on Trolley and bus services in the area.
Oxford Global has secured a number of bedrooms at the Doubletree by Hilton San Diego Mission Valley at a reduced conference rate:
- Sunday 27th October 2024 – $265 (includes room rate, taxes & daily continental breakfast)
- Monday 28th October 2024 – $265 (includes room rate, taxes & daily continental breakfast)
Should you wish to book a room, please click here.
The final cut-off date to book bedrooms is Friday 27th September 2024 – any bookings after this date are subject to availability and rates - any cancellations after 4th October are subject to full cancellation charges.
Additionally, we kindly remind all attendees to only book their accommodation if they are registered for the event. This ensures that accommodations are available for those who have officially secured their attendance.
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Advances in Immuno-Oncology US 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.
